Syahir Mansor1, Ronald Boellaard2, Femke E Froklage3, Esther D M Bakker2, Maqsood Yaqub2, Rob A Voskuyl3, Lothar A Schwarte4, Joost Verbeek2, Albert D Windhorst2, Adriaan Lammertsma2. 1. Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands m.mansor@vumc.nl. 2. Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands; and. 4. Department of Anaesthesiology, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
UNLABELLED: The overexpression of P-glycoprotein (Pgp) is thought to be an important mechanism of pharmacoresistance in epilepsy. Recently, (11)C-phenytoin has been evaluated preclinically as a tracer for Pgp. The aim of the present study was to assess the optimal plasma kinetic model for quantification of (11)C-phenytoin studies in humans. METHODS: Dynamic (11)C-phenytoin PET scans of 6 healthy volunteers with arterial sampling were acquired twice on the same day and analyzed using single- and 2-tissue-compartment models with and without a blood volume parameter. Global and regional test-retest (TRT) variability was determined for both plasma to tissue rate constant (K1) and volume of distribution (VT). RESULTS: According to the Akaike information criterion, the reversible single-tissue-compartment model with blood volume parameter was the preferred plasma input model. Mean TRT variability ranged from 1.5% to 16.9% for K1 and from 0.5% to 5.8% for VT. Larger volumes of interest showed better repeatabilities than smaller regions. A 45-min scan provided essentially the same K1 and VT values as a 60-min scan. CONCLUSION: A reversible single-tissue-compartment model with blood volume seems to be a good candidate model for quantification of dynamic (11)C-phenytoin studies. Scan duration may be reduced to 45 min without notable loss of accuracy and precision of both K1 and VT, although this still needs to be confirmed under pathologic conditions.
UNLABELLED: The overexpression of P-glycoprotein (Pgp) is thought to be an important mechanism of pharmacoresistance in epilepsy. Recently, (11)C-phenytoin has been evaluated preclinically as a tracer for Pgp. The aim of the present study was to assess the optimal plasma kinetic model for quantification of (11)C-phenytoin studies in humans. METHODS: Dynamic (11)C-phenytoin PET scans of 6 healthy volunteers with arterial sampling were acquired twice on the same day and analyzed using single- and 2-tissue-compartment models with and without a blood volume parameter. Global and regional test-retest (TRT) variability was determined for both plasma to tissue rate constant (K1) and volume of distribution (VT). RESULTS: According to the Akaike information criterion, the reversible single-tissue-compartment model with blood volume parameter was the preferred plasma input model. Mean TRT variability ranged from 1.5% to 16.9% for K1 and from 0.5% to 5.8% for VT. Larger volumes of interest showed better repeatabilities than smaller regions. A 45-min scan provided essentially the same K1 and VT values as a 60-min scan. CONCLUSION: A reversible single-tissue-compartment model with blood volume seems to be a good candidate model for quantification of dynamic (11)C-phenytoin studies. Scan duration may be reduced to 45 min without notable loss of accuracy and precision of both K1 and VT, although this still needs to be confirmed under pathologic conditions.
Authors: Jeih-San Liow; Sami S Zoghbi; Shuo Hu; Matthew D Hall; Christina S Hines; H Umesha Shetty; Maria D Araneta; Emily M Page; Victor W Pike; William C Kreisl; Peter Herscovitch; Michael M Gottesman; William H Theodore; Robert B Innis Journal: Neuroimage Date: 2016-05-19 Impact factor: 6.556
Authors: Nicolas Tournier; Martin Bauer; Verena Pichler; Lukas Nics; Eva-Maria Klebermass; Karsten Bamminger; Peter Matzneller; Maria Weber; Rudolf Karch; Fabien Caillé; Sylvain Auvity; Solène Marie; Walter Jäger; Wolfgang Wadsak; Marcus Hacker; Markus Zeitlinger; Oliver Langer Journal: J Nucl Med Date: 2019-01-10 Impact factor: 11.082
Authors: Sandeep S V Golla; Sofie M Adriaanse; Maqsood Yaqub; Albert D Windhorst; Adriaan A Lammertsma; Bart N M van Berckel; Ronald Boellaard Journal: EJNMMI Phys Date: 2017-12-06
Authors: Lara García-Varela; David Vállez García; Manuel Rodríguez-Pérez; Aren van Waarde; Jürgen W A Sijbesma; Anna Schildt; Chantal Kwizera; Pablo Aguiar; Tomás Sobrino; Rudi A J O Dierckx; Philip H Elsinga; Gert Luurtsema Journal: ACS Chem Neurosci Date: 2020-02-03 Impact factor: 4.418